Page last updated: 2024-08-24

toborinone and Cardiac Failure

toborinone has been researched along with Cardiac Failure in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (72.73)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Young, JB1
Bramer, SL; Kitani, M; Miyamoto, G; Tammara, B; Trang, JM1
Bhat, G; Burwig, S; Eppert, D; Hoit, BD; Walsh, RA1
Feldman, AM; Strobeck, JE1
Ishihara, H; Kanda, H; Kato, R; Nagata, K; Sobue, T; Yokota, M1
Fujiki, H; Itoh, S; Mori, T; Tominaga, M1
Abraham, WT; Bristow, MR; Ferguson, DA; Lindenfeld, J; Lowes, BD; Scheffel, CA; White, M; Wolfel, EE1
Cowart, TD; Feldman, MD; Haber, HL; MacGowan, GA; Tedesco, C; Wu, C1
Belenkie, I; Semeniuk, LM; Tyberg, JV1
Akamatsu, T; Hirata, T; Horinokuchi, N; Kuro, M; Uchida, O1
MacGowan, GA1

Reviews

3 review(s) available for toborinone and Cardiac Failure

ArticleYear
New therapeutic choices in the management of acute congestive heart failure.
    Reviews in cardiovascular medicine, 2001, Volume: 2 Suppl 2

    Topics: Acute Disease; Heart Failure; Humans; Hydrazones; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Quinolones; Simendan; Treatment Outcome; Vasodilator Agents

2001
Quinolinone derivatives in the management of congestive heart failure.
    Coronary artery disease, 1994, Volume: 5, Issue:2

    Topics: Animals; Cardiotonic Agents; Heart Failure; Humans; Pyrazines; Quinolines; Quinolones

1994
Clinical overview of the novel inotropic agent toborinone.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:5

    Topics: Animals; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Quinolones

2000

Trials

4 trial(s) available for toborinone and Cardiac Failure

ArticleYear
The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:12

    Topics: Adult; Aged; Cardiotonic Agents; Chromatography, High Pressure Liquid; Female; Heart Failure; Humans; Indicators and Reagents; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Quinolones; Reproducibility of Results; Time Factors

2002
Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    American heart journal, 1994, Volume: 128, Issue:6 Pt 1

    Topics: Adult; Aged; Cardiotonic Agents; Diastole; Double-Blind Method; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Quinolones; Radionuclide Ventriculography; Stroke Volume; Systole; Ventricular Function, Left

1994
A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    American heart journal, 1996, Volume: 132, Issue:2 Pt 1

    Topics: Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Prospective Studies; Quinolones; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left

1996
Study on the effectiveness of toborinone (OPC-18790) in the treatment of heart failure in patients following cardiac surgery.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:6

    Topics: Aged; Cardiac Surgical Procedures; Cardiotonic Agents; Extracorporeal Circulation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Postoperative Complications; Quinolones

1999

Other Studies

4 other study(ies) available for toborinone and Cardiac Failure

ArticleYear
Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:12

    Topics: Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Quinolones; Ventricular Function, Left

1996
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Journal of cardiac failure, 1994, Volume: 1, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left

1994
Direct myocardial effects of OPC-18790 in human heart failure: beneficial effects on contractile and diastolic function demonstrated by intracoronary infusion with pressure-volume analysis.
    Journal of the American College of Cardiology, 1998, Volume: 31, Issue:6

    Topics: Aged; Cardiac Catheterization; Cardiotonic Agents; Diastole; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Myocardial Contraction; Quinolones; Systole; Treatment Outcome; Ventricular Function

1998
Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure.
    Circulation, 1998, Jul-07, Volume: 98, Issue:1

    Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Enalaprilat; Female; Heart Failure; Hemodynamics; Hydralazine; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Quinolones; Vascular Capacitance; Vasodilator Agents

1998